Boston Scientific Corporation (BSX)’in fiyatı nedir?

Boston Scientific Corporation (BSX)’in fiyatı $48.86’dir

Boston Scientific Corporation (BSX)’in piyasa değeri nedir?

Boston Scientific Corporation (BSX)’in piyasa değeri $72.62B’dir.

Boston Scientific Corporation (BSX) Tedavüldeki Hisseler

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
2026 (TTM)	1.48B	-0.19%
2025	1.48B	0.60%
2024	1.47B	1.27%
2023	1.45B	1.57%
2022	1.43B	0.58%
2021	1.42B	0.40%
2020	1.42B	1.81%
2019	1.39B	0.76%
2018	1.38B	0.80%
2017	1.37B	0.92%
2016	1.36B	2.25%
2015	1.33B	0.26%
2014	1.32B	-1.26%
2013	1.34B	-4.66%
2012	1.41B	-6.80%
2011	1.51B	-0.56%
2010	1.52B	0.66%
2009	1.51B	0.63%
2008	1.50B	0.78%
2007	1.49B	16.74%
2006	1.27B	54.14%
2005	826.32M	-1.18%
2004	836.22M	0.98%
2003	828.07M	2.12%
2002	810.87M	-2.40%
2001	830.77M	2.45%
2000	810.87M	0.00%

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

2026 (TTM)

1.48B

-0.19%

2025

1.48B

0.60%

2024

1.47B

1.27%

2023

1.45B

1.57%

2022

1.43B

0.58%

2021

1.42B

0.40%

2020

1.42B

1.81%

2019

1.39B

0.76%

2018

1.38B

0.80%

2017

1.37B

0.92%

2016

1.36B

2.25%

2015

1.33B

0.26%

2014

1.32B

-1.26%

2013

1.34B

-4.66%

2012

1.41B

-6.80%

2011

1.51B

-0.56%

2010

1.52B

0.66%

2009

1.51B

0.63%

2008

1.50B

0.78%

2007

1.49B

16.74%

2006

1.27B

54.14%

2005

826.32M

-1.18%

2004

836.22M

0.98%

2003

828.07M

2.12%

2002

810.87M

-2.40%

2001

830.77M

2.45%

2000

810.87M

0.00%

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
Abbott Laboratories ABT.US	1.74B	17.96%	US
Stryker Corporation SYK.US	383.50M	-74.05%	US
Medtronic plc MDT.US	1.28B	-13.23%	IE
Edwards Lifesciences Corporation EW.US	576.40M	-60.99%	US
Siemens Healthineers AG SHL.DE	-	-	DE

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke